Newsroom
October 1, 2024
Bioventus Announces Divestiture of its Advanced Rehabilitation Business to Accelmed Partners
DURHAM, N.C., Oct. 01, 2024 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for…
January 18, 2024
Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility
DURHAM, NC – January 18, 2023 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today…
January 2, 2024
Robert Claypoole Named CEO
Seasoned Leader Brings More than Two Decades of Medical Device Experience and Proven Track Record of Driving Revenue and Operating Margin Growth…
December 5, 2023
Bioventus Agrees to Nationwide Contract with Aetna Medicare Advantage Plans for DUROLANE for Knee Osteoarthritis
DURHAM, NC – Dec. 5, 2023 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has…
May 10, 2023
Bioventus Announces Divestiture of its Wound Business
DURHAM, N.C., May 10, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active…
October 14, 2022
Bioventus to Showcase Full Orthobiologics and Ultrasonic Portfolio at NASS in Chicago
Bioventus to Showcase Full Orthobiologics and Ultrasonic Portfolio at NASS in Chicago Full Launch of BoneScalpel Access® at NASS DURHAM, NC –…
July 12, 2022
Bioventus Completes CartiHeal Acquisition
Bioventus Completes CartiHeal Acquisition DURHAM, NC – July 12, 2022 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader…
June 21, 2022
Bioventus Amends CartiHeal Acquisition Structure
Bioventus Amends CartiHeal Acquisition Structure DURHAM, NC – June 21, 2022 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global…
April 4, 2022
Bioventus Exercises Call Option to Acquire CartiHeal
DURHAM, NC – April 4, 2022 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today…
March 1, 2022
Bioventus Receives 510(k) Clearance for StimRouter Pain Management Device
Industry Leading Peripheral Nerve Stimulator Upgraded to Improve Patient User Experience with Control of their Unique Chronic Pain Condition, Longer…
